Ledent, E.
GlaxoSmithKline (Belgium)
2 papers on CoChatORCID 0000-0003-3464-1247
Most cited papers
- Verified
Safety and Immunogenicity of an AS01-adjuvanted Varicella-zoster Virus Subunit Candidate Vaccine Against Herpes Zoster in Adults >=50 Years of Age
Chlibek, R., Bayas, J. M., Collins, H., de la Pinta, M. L. R., Ledent, E., Mols, J. F., & Heineman, T. C. (2013) · Journal of Infectious Diseases
Herpesvirus Infections and TreatmentsImmunotherapy and Immune Responses
Cited by 149
- Verified
A Phase 1/2 Clinical Trial Evaluating Safety and Immunogenicity of a Varicella Zoster Glycoprotein E Subunit Vaccine Candidate in Young and Older Adults
Leroux-Roels, I., Leroux-Roels, G., Clement, F., Vandepapelière, P., Vassilev, V., Ledent, E., & Heineman, T. C. (2012) · The Journal of Infectious Diseases
Herpesvirus Infections and TreatmentsCytomegalovirus and herpesvirus research
Cited by 147
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free